JP2024519515A5 - - Google Patents

Info

Publication number
JP2024519515A5
JP2024519515A5 JP2023561608A JP2023561608A JP2024519515A5 JP 2024519515 A5 JP2024519515 A5 JP 2024519515A5 JP 2023561608 A JP2023561608 A JP 2023561608A JP 2023561608 A JP2023561608 A JP 2023561608A JP 2024519515 A5 JP2024519515 A5 JP 2024519515A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
cell
cells
ipsc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023561608A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024519515A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/022793 external-priority patent/WO2022216514A1/en
Publication of JP2024519515A publication Critical patent/JP2024519515A/ja
Publication of JP2024519515A5 publication Critical patent/JP2024519515A5/ja
Pending legal-status Critical Current

Links

JP2023561608A 2021-04-07 2022-03-31 人工多能性幹細胞からガンマ-デルタt細胞を生成するための組成物および方法 Pending JP2024519515A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163171646P 2021-04-07 2021-04-07
US63/171,646 2021-04-07
US202163279837P 2021-11-16 2021-11-16
US63/279,837 2021-11-16
PCT/US2022/022793 WO2022216514A1 (en) 2021-04-07 2022-03-31 Compositions and methods for generating gamma-delta t cells from induced pluripotent stem cells

Publications (2)

Publication Number Publication Date
JP2024519515A JP2024519515A (ja) 2024-05-15
JP2024519515A5 true JP2024519515A5 (cg-RX-API-DMAC10.html) 2025-04-08

Family

ID=81648414

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023561608A Pending JP2024519515A (ja) 2021-04-07 2022-03-31 人工多能性幹細胞からガンマ-デルタt細胞を生成するための組成物および方法

Country Status (11)

Country Link
US (2) US20220333073A1 (cg-RX-API-DMAC10.html)
EP (1) EP4320227A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024519515A (cg-RX-API-DMAC10.html)
KR (1) KR20230170703A (cg-RX-API-DMAC10.html)
AU (1) AU2022252997A1 (cg-RX-API-DMAC10.html)
BR (1) BR112023018844A2 (cg-RX-API-DMAC10.html)
CA (1) CA3214045A1 (cg-RX-API-DMAC10.html)
IL (1) IL307358A (cg-RX-API-DMAC10.html)
MX (1) MX2023011927A (cg-RX-API-DMAC10.html)
TW (1) TW202305113A (cg-RX-API-DMAC10.html)
WO (1) WO2022216514A1 (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL303269A (en) 2020-12-03 2023-07-01 Century Therapeutics Inc Genetically engineered cells and uses thereof
EP4289940A4 (en) * 2021-02-05 2025-02-26 National University Corporation Kobe University ?? T-CELLS FROM INDUCED PLURIPOTENT STEM CELLS AND PRODUCTION PROCESSES THEREFOR
IL314801A (en) 2022-02-22 2024-10-01 Juno Therapeutics Inc Proteinase 3 (PR3) Chimeric Autoantigen Receptor T Cells and Related Methods and Uses
CN119630695A (zh) 2022-06-08 2025-03-14 世纪治疗股份有限公司 表达cd16变体和nkg2d的遗传工程化细胞及其用途
CN120435498A (zh) 2022-11-10 2025-08-05 世纪治疗股份有限公司 具有抗-nectin4嵌合抗原受体的基因工程化细胞及其用途
WO2024191989A1 (en) * 2023-03-14 2024-09-19 Shattuck Labs, Inc. Treatment of b cell-mediated diseases by activating cd20-targeted gamma delta t cells
US20260234216A1 (en) * 2023-03-30 2026-08-13 Yale University Universal antibody receptors, guar-t cells and therapeutic use thereof
WO2024254013A1 (en) * 2023-06-04 2024-12-12 Cytovia Therapeutics, Llc. Natural killer cells with novel il-15 knock-in and methods of use thereof
WO2025101938A2 (en) 2023-11-10 2025-05-15 Century Therapeutics, Inc. Genetically engineered cells having multi-transmembrane domain chimeric antigen receptors utilizing g protein-coupled receptor scaffolds, and uses thereof
WO2025106626A1 (en) 2023-11-15 2025-05-22 Century Therapeutics, Inc. Genetically engineered cells expressing c-x-c chemokine receptor type 4, and uses thereof
CN118845737A (zh) * 2024-07-08 2024-10-29 海南大学 托瑞米芬在增强γδT细胞抗肿瘤功能中的应用

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344321B1 (en) 1990-06-11 2002-02-05 Gilead Sciences, Inc. Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met
DE69334275D1 (de) 1992-08-21 2009-05-20 Univ Bruxelles Immunoglobuline ohne Leichtkette
GB9710809D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
GB9710807D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
US6140081A (en) 1998-10-16 2000-10-31 The Scripps Research Institute Zinc finger binding domains for GNN
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
JP2002060786A (ja) 2000-08-23 2002-02-26 Kao Corp 硬質表面用殺菌防汚剤
US20040224385A1 (en) 2001-08-20 2004-11-11 Barbas Carlos F Zinc finger binding domains for cnn
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US7972854B2 (en) 2004-02-05 2011-07-05 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US8574179B2 (en) 2004-09-17 2013-11-05 Stp Swiss Therapeutic Products Ag Enhanced biomechanical stimulation device
DK3399025T3 (da) 2007-03-23 2025-06-16 Wisconsin Alumni Res Found Omprogrammering af somatiske celler
ES2587395T3 (es) 2008-06-04 2016-10-24 Cellular Dynamics International, Inc. Procedimientos para la producción de células IPS usando un enfoque no vírico
EP3450545B1 (en) 2008-10-24 2023-08-23 Wisconsin Alumni Research Foundation Pluripotent stem cells obtained by non-viral reprogramming
CA2753679C (en) 2009-02-27 2021-03-02 Cellular Dynamics International, Inc. Differentiation of pluripotent cells
EP4420730A3 (en) 2009-03-19 2024-11-13 The Johns Hopkins University Psma-targeting compounds and uses thereof
PT2816112T (pt) 2009-12-10 2018-11-20 Univ Iowa State Res Found Inc Modificação do adn modificada pelo efector tal
US9206394B2 (en) 2010-02-03 2015-12-08 The University Of Tokyo Method for reconstructing immune function using pluripotent stem cells
EP2601289B1 (en) 2010-08-04 2017-07-12 Cellular Dynamics International, Inc. Reprogramming immortalized b cells
WO2012109208A2 (en) 2011-02-08 2012-08-16 Cellular Dynamics International, Inc. Hematopoietic precursor cell production by programming
DE102012006356A1 (de) 2012-03-28 2013-10-02 Audi Ag Kraftfahrzeug, umfassend mehrere aktive oder passive Sicherheitsvorrichtungen
US9932607B2 (en) 2013-11-15 2018-04-03 The Board Of Trustees Of The Leland Stanford Junior University Site-specific integration of transgenes into human cells
WO2015143029A1 (en) 2014-03-18 2015-09-24 The Johns Hopkins University Psma-based molecular-genetic reporter system
AU2015290554A1 (en) 2014-07-18 2017-03-09 Kyoto University Method for inducing T cells for cell-based immunotherapy from pluripotent stem cells
WO2017070333A1 (en) 2015-10-20 2017-04-27 Cellular Dynamics International, Inc. Multi-lineage hematopoietic precursor cell production by genetic programming
JP6976960B2 (ja) * 2015-11-27 2021-12-08 カーサリクス プロプライエタリー リミテッド 遺伝子改変された細胞およびその使用
LT3444334T (lt) 2016-04-15 2021-12-10 Kyoto University Antigenui specifinių cd8 teigiamų t ląstelių indikavimo būdas
CN118546961A (zh) 2016-08-26 2024-08-27 贝勒医学院 用于细胞治疗的组成型活性细胞因子受体
JP7215994B2 (ja) 2016-09-06 2023-01-31 ザ チルドレンズ メディカル センター コーポレーション 人工多能性幹細胞由来の免疫細胞
KR102397771B1 (ko) 2016-09-23 2022-05-13 프레드 헛친슨 켄서 리서치 센터 부 조직적합성(h) 항원 ha-1에 대해서 특이적인 tcr 및 이의 용도
JP7212615B2 (ja) 2016-10-05 2023-01-25 フジフィルム セルラー ダイナミクス,インコーポレイテッド 多能性幹細胞からhlaホモ接合免疫細胞への指向分化方法
EP3572502B1 (en) * 2017-01-20 2023-01-11 Kyoto University Method for producing cd8alpha +beta + cytotoxic t cells
JP7224021B2 (ja) * 2017-02-03 2023-02-17 国立大学法人神戸大学 人工多能性幹細胞の作製方法
MX2019012017A (es) 2017-04-07 2020-02-12 Juno Therapeutics Inc Celulas modificadas que expresan antigeno de membrana especifico de prostata (psma) o una forma modificada del mismo y metodos relacionados.
CN110891967B (zh) 2017-04-18 2025-03-14 富士胶片细胞动力公司 抗原特异性免疫效应细胞
TW201908335A (zh) 2017-07-25 2019-03-01 美國德州系統大學評議委員會 增強之嵌合抗原受體及其用途
EP3684816B1 (en) 2017-09-22 2024-05-29 Kite Pharma, Inc. Chimeric polypeptides and uses thereof
EP3692057B9 (en) 2017-10-03 2023-10-04 Precision BioSciences, Inc. Modified epidermal growth factor receptor peptides for use in genetically-modified cells
CN111556892A (zh) * 2017-12-08 2020-08-18 菲特治疗公司 使用增强的iPSC衍生的效应细胞的免疫疗法
EP3822342A4 (en) * 2018-07-13 2022-08-03 Kyoto University METHOD OF PRODUCTION OF GAMMA DELTA T-CELLS
AU2019345052B2 (en) 2018-09-19 2025-09-04 FUJIFILM Cellular Dynamics, Inc. Protein L for activation and expansion of chimeric antigen receptor-modified immune cells
EP4578507A3 (en) * 2018-11-01 2025-11-12 Gracell Biotechnologies (Shanghai) Co., Ltd. Compositions and methods for t cell engineering
JP7747352B2 (ja) * 2020-12-28 2025-10-01 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 操作されたガンマデルタt細胞ならびにその作製方法および使用方法

Similar Documents

Publication Publication Date Title
US12233090B2 (en) Bispecific or-gate chimeric antigen receptor responsive to CD20 and CD19
US20250002579A1 (en) Chimeric antigen receptors and methods of making
US20250034217A1 (en) Nucleic acid constructs for co-expression of chimeric antigen receptor and transcription factor, cells containing and therapeutic use thereof
US12060585B2 (en) Expression of novel cell tags
JP2024513906A5 (cg-RX-API-DMAC10.html)
US12304935B2 (en) Immunomodulatory polypeptides and related compositions and methods
JP2023553419A5 (cg-RX-API-DMAC10.html)
JP2022553818A (ja) 二重標的キメラ抗原レセプターt細胞療法のためのプロテアーゼスイッチ
TWI862531B (zh) 突變型piggyBac轉位酶
RS63574B1 (sr) Metode za povećanje efikasnosti imuno ćelija
WO2015028444A1 (en) Anti cd30 chimeric antigen receptor and its use
JP2025501214A5 (cg-RX-API-DMAC10.html)
CA3076547A1 (en) Anti-hla-a2 antibodies and uses thereof
TW202300528A (zh) 嵌合抗原受體
KR20210111244A (ko) 태반-유래 동종이계 car-t 세포 및 이의 용도
WO2024193714A1 (zh) 细胞免疫疗法的组合物和方法
HK40115184A (en) Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20
CN119331823A (zh) 用于工程化t细胞制备的病毒颗粒及其用途
JP2024545870A (ja) 血小板減少症を治療するための製品及び方法
CN117778328A (zh) 一种通用型bcma car-t细胞的增殖方法
CN121800931A (zh) 靶向cll1的增强型嵌合抗原受体及其应用
KR20260022392A (ko) 융합 단백질 및 그의 의학적 용도
CN116157415A (zh) 靶向抗rh抗体的组合物和方法
HK40030175A (en) Chimeric antigen receptors and methods of making
HK1232561A1 (en) Chimeric antigen receptors and methods of making